3S – Systematic, Systemic, and Systems Biology and Toxicology
暂无分享,去创建一个
Raffaella Corvi | Nicole Kleinstreuer | Andre Levchenko | Thomas Hartung | Lena Smirnova | L. Smirnova | A. Levchenko | T. Hartung | S. Fitzpatrick | R. Corvi | N. Kleinstreuer | Suzanne C Fitzpatrick
[1] Linda S Birnbaum,et al. Cancer and developmental exposure to endocrine disruptors. , 2002, Environmental health perspectives.
[2] R. Tyl,et al. Critical evaluation of current developmental toxicity testing strategies: a case of babies and their bathwater. , 2011, Birth defects research. Part B, Developmental and reproductive toxicology.
[3] Bas J Blaauboer,et al. An expert consortium review of the EC-commissioned report "alternative (Non-Animal) methods for cosmetics testing: current status and future prospects - 2010". , 2011, ALTEX.
[4] R. Tennant,et al. Genetically altered mouse models for identifying carcinogens. , 1999, IARC scientific publications.
[5] J. Haseman,et al. The role of transgenic mouse models in carcinogen identification. , 2002, Environmental health perspectives.
[6] Gary R. Mirams,et al. Systems Toxicology: Real World Applications and Opportunities , 2017, Chemical research in toxicology.
[7] T. Hartung. Look back in anger - what clinical studies tell us about preclinical work. , 2013, ALTEX.
[8] T. Kennedy. Managing the drug discovery/development interface , 1997 .
[9] J. Kleinjans,et al. Testing chemical carcinogenicity by using a transcriptomics HepaRG-based model? , 2014, EXCLI journal.
[10] C L Alden,et al. A Critical Review of the Effectiveness of Rodent Pharmaceutical Carcinogenesis Testing in Predicting for Human Risk , 2011, Veterinary pathology.
[11] Michael L Shuler,et al. Human-on-a-chip design strategies and principles for physiologically based pharmacokinetics/pharmacodynamics modeling. , 2015, Integrative biology : quantitative biosciences from nano to macro.
[12] Ivan Rusyn,et al. Key Characteristics of Carcinogens as a Basis for Organizing Data on Mechanisms of Carcinogenesis , 2015, Environmental health perspectives.
[13] Raffaella Corvi,et al. How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop. , 2007, Mutation research.
[14] Michael Schwarz,et al. The integrated project ReProTect: a novel approach in reproductive toxicity hazard assessment. , 2005, Reproductive toxicology.
[15] T Seidle,et al. The development of new concepts for assessing reproductive toxicity applicable to large scale toxicological programmes. , 2007, Current pharmaceutical design.
[16] Jan G. Hengstler,et al. Highlight report: towards the replacement of in vivo repeated dose systemic toxicity testing , 2011, Archives of Toxicology.
[17] Thomas Hartung,et al. Optimisation of the Post-validation Process , 2008, Alternatives to laboratory animals : ATLA.
[18] Thomas Hartung,et al. Good cell culture practices &in vitro toxicology. , 2017, Toxicology in vitro : an international journal published in association with BIBRA.
[19] Raffaella Corvi,et al. In vitro genotoxicity testing-Can the performance be enhanced? , 2017, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[20] Julie E Goodman,et al. A primer on systematic reviews in toxicology , 2017, Archives of Toxicology.
[21] J. Marx. Building Better Mouse Models for Studying Cancer , 2003, Science.
[22] P. Sorger,et al. Sequential Application of Anticancer Drugs Enhances Cell Death by Rewiring Apoptotic Signaling Networks , 2012, Cell.
[23] Martin Paparella,et al. Uncertainties of testing methods: What do we (want to) know about carcinogenicity? , 2016, ALTEX.
[24] G. Daston,et al. Skeletal malformations and variations in developmental toxicity studies: interpretation issues for human risk assessment. , 2007, Birth defects research. Part B, Developmental and reproductive toxicology.
[25] T. Knudsen,et al. A roadmap for the development of alternative (non-animal) methods for systemic toxicity testing. , 2012, ALTEX.
[26] Lester B Lave,et al. Implications of the lack of accuracy of the lifetime rodent bioassay for predicting human carcinogenicity. , 2003, Regulatory toxicology and pharmacology : RTP.
[27] Bernadette Modell,et al. March of Dimes: global report on birth defects, the hidden toll of dying and disabled children. , 2005 .
[28] David M. Reif,et al. Analysis of the Effects of Cell Stress and Cytotoxicity onIn Vitro Assay Activity Across a Diverse Chemical and Assay Space , 2016, Toxicological sciences : an official journal of the Society of Toxicology.
[29] Thomas Hartung,et al. Computational Approaches to Chemical Hazard Assessment , 2017, ALTEX.
[30] S. H. Bennekou,et al. Adverse outcome pathways: opportunities, limitations and open questions , 2017, Archives of Toxicology.
[31] Herbert S. Rosenkranz,et al. Information value of the rodent bioassay , 1988, Nature.
[32] T. Hartung. Toxicology for the twenty-first century , 2009, Nature.
[33] Robert J Kavlock,et al. Phenotypic screening of the ToxCast chemical library to classify toxic and therapeutic mechanisms , 2014, Nature Biotechnology.
[34] Thomas Hartung,et al. Making big sense from big data in toxicology by read-across. , 2016, ALTEX.
[35] Thomas Hartung,et al. Food for thought... on animal tests. , 2008, ALTEX.
[36] Valérie Zuang,et al. A Modular Approach to the ECVAM Principles on Test Validity , 2004, Alternatives to laboratory animals : ATLA.
[37] M. Aardema,et al. ECVAM prevalidation study on in vitro cell transformation assays: general outline and conclusions of the study. , 2012, Mutation research.
[38] T Hartung,et al. Toward an evidence-based toxicology , 2006, Human & experimental toxicology.
[39] Richard R Rabbit,et al. How are reproductive toxicity and developmental toxicity addressed in REACH dossiers? , 2011, ALTEX.
[40] M. Pike,et al. Some tautologous aspects of the comparison of carcinogenic potency in rats and mice. , 1985, Fundamental and applied toxicology : official journal of the Society of Toxicology.
[41] Susanne Bremer,et al. Validation of the Embryonic Stem Cell Test in the International ECVAM Validation Study on Three In Vitro Embryotoxicity Tests , 2004, Alternatives to laboratory animals : ATLA.
[42] B. Ames,et al. What do animal cancer tests tell us about human cancer risk?: Overview of analyses of the carcinogenic potency database. , 1998, Drug metabolism reviews.
[43] T. Collins. History and evolution of reproductive and developmental toxicology guidelines. , 2006, Current pharmaceutical design.
[44] Weida Tong,et al. Toward predictive models for drug-induced liver injury in humans: are we there yet? , 2014, Biomarkers in medicine.
[45] G. Lahav,et al. Schedule-dependent interaction between anticancer treatments , 2016, Science.
[46] C Helma,et al. Data quality in predictive toxicology: reproducibility of rodent carcinogenicity experiments. , 2001, Environmental health perspectives.
[47] Thomas Hartung,et al. Food for thought... on evidence-based toxicology. , 2009, ALTEX.
[48] T. Knudsen,et al. Screening for angiogenic inhibitors in zebrafish to evaluate a predictive model for developmental vascular toxicity. , 2017, Reproductive toxicology.
[49] Thomas Hartung,et al. Utility of the adverse outcome pathway concept in drug development , 2017, Expert opinion on drug metabolism & toxicology.
[50] Thomas Hartung,et al. Chemical regulators have overreached , 2009, Nature.
[51] Ruili Huang,et al. Development and Validation of a Computational Model for Androgen Receptor Activity , 2016, Chemical research in toxicology.
[52] L. Smirnova,et al. Cellular resilience. , 2015, ALTEX.
[53] Raffaella Corvi,et al. Moving forward in carcinogenicity assessment: Report of an EURL ECVAM/ESTIV workshop , 2017, Toxicology in vitro : an international journal published in association with BIBRA.
[54] N A Brown,et al. The value of animal teratogenicity testing for predicting human risk. , 1983, Clinical obstetrics and gynecology.
[55] Jiri Aubrecht,et al. Validation of Transcriptomics-Based In Vitro Methods. , 2016, Advances in experimental medicine and biology.
[56] Wout Slob,et al. A retrospective analysis of the two-generation study: what is the added value of the second generation? , 2007, Reproductive toxicology.
[57] Ivan Rusyn,et al. Use of high-throughput in vitro toxicity screening data in cancer hazard evaluations by IARC Monograph Working Groups. , 2018, ALTEX.
[58] H. Kubinyi. Drug research: myths, hype and reality , 2003, Nature Reviews Drug Discovery.
[59] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[60] E. Silbergeld. Commentary: The Rôle of Toxicology in Prevention and Precaution , 2005, International journal of occupational medicine and environmental health.
[61] U. Thorgeirsson,et al. Chemical carcinogenesis studies in nonhuman primates. , 2008, Basic life sciences.
[62] Mardas Daneshian,et al. Consensus report on the future of animal-free systemic toxicity testing. , 2014, ALTEX.
[63] M E Hurtt,et al. Proposal for a tiered approach to developmental toxicity testing for veterinary pharmaceutical products for food-producing animals. , 2003, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[64] Nancy C. Baker,et al. Systems Toxicology of Male Reproductive Development: Profiling 774 Chemicals for Molecular Targets and Adverse Outcomes , 2015, Environmental health perspectives.
[65] D. Mattison. Environmental exposures and development , 2010, Current opinion in pediatrics.
[66] Anne Hersey,et al. Legacy data sharing to improve drug safety assessment: the eTOX project , 2017, Nature Reviews Drug Discovery.
[67] I. Shlyakhter,et al. An empirical examination of factors influencing prediction of carcinogenic hazard across species. , 1995, Regulatory toxicology and pharmacology : RTP.
[68] Bing Wang,et al. Concordance of Noncarcinogenic Endpoints in Rodent Chemical Bioassays , 2015, Risk analysis : an official publication of the Society for Risk Analysis.
[69] D. Freedman,et al. From Mouse-to-Man: The Quantitative Assessment of Cancer Risks , 1988 .
[70] Mardas Daneshian,et al. Advanced Good Cell Culture Practice for human primary, stem cell-derived and organoid models as well as microphysiological systems. , 2018, ALTEX.
[71] R. Blust,et al. Feasibility study of the zebrafish assay as an alternative method to screen for developmental toxicity and embryotoxicity using a training set of 27 compounds. , 2012, Reproductive toxicology.
[72] David M. Reif,et al. Profiling Chemicals Based on Chronic Toxicity Results from the U.S. EPA ToxRef Database , 2008, Environmental health perspectives.
[73] B. Kholodenko. Drug Resistance Resulting from Kinase Dimerization Is Rationalized by Thermodynamic Factors Describing Allosteric Inhibitor Effects. , 2015, Cell reports.
[74] E Sabbioni,et al. Cell Transformation Assays as Predictors of Human Carcinogenicity , 1999, Alternatives to laboratory animals : ATLA.
[75] Wout Slob,et al. Deriving a Data-Based Interspecies Assessment Factor Using the NOAEL and the Benchmark Dose Approach , 2007, Critical reviews in toxicology.
[76] Paul Jennings,et al. Stem cell-derived systems in toxicology assessment. , 2015, Stem cells and development.
[77] T. Knudsen,et al. Identification of vascular disruptor compounds by analysis in zebrafish embryos and mouse embryonic endothelial cells. , 2017, Reproductive toxicology.
[78] T. Luechtefeld,et al. The Threshold of Toxicological Concern for prenatal developmental toxicity in rats and rabbits , 2017, Regulatory toxicology and pharmacology : RTP.
[79] I. Cockburn,et al. The Economics of Reproducibility in Preclinical Research , 2015, PLoS biology.
[80] Anthony R Scialli,et al. Thalidomide: the tragedy of birth defects and the effective treatment of disease. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.
[81] Daniel P. Russo,et al. Global Analysis of Publicly Available Safety Data for 9,801 Substances Registered under REACH from 2008–2014 , 2016, ALTEX.
[82] L. Smirnova,et al. Rotenone exerts developmental neurotoxicity in a human brain spheroid model , 2018, Toxicology and applied pharmacology.
[83] Aldert H Piersma,et al. Validation of the Postimplantation Rat Whole-embryo Culture Test in the International ECVAM Validation Study on Three In Vitro Embryotoxicity Tests , 2004, Alternatives to laboratory animals : ATLA.
[84] L. Bernstein,et al. Target organs in chronic bioassays of 533 chemical carcinogens. , 1991, Environmental health perspectives.
[85] Angelo Moretto,et al. A Tiered Approach to Systemic Toxicity Testing for Agricultural Chemical Safety Assessment , 2006, Critical reviews in toxicology.
[86] B. van Ravenzwaay,et al. The threshold of toxicological concern for prenatal developmental toxicity. , 2011, Regulatory toxicology and pharmacology : RTP.
[87] F. K. Ennever,et al. The predictivity of animal bioassays and short-term genotoxicity tests for carcinogenicity and non-carcinogenicity to humans. , 1987, Mutagenesis.
[88] Francois Busquet,et al. The need for strategic development of safety sciences. , 2017, ALTEX.
[89] Robert J Kavlock,et al. Profiling the reproductive toxicity of chemicals from multigeneration studies in the toxicity reference database. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.
[90] U. Gundert-Remy,et al. Exposure-triggered reproductive toxicity testing under the REACH legislation: a proposal to define significant/relevant exposure. , 2008, Toxicology letters.
[91] R. Rudel,et al. Environmental chemicals and breast cancer: An updated review of epidemiological literature informed by biological mechanisms , 2018, Environmental research.
[92] Melvin E Andersen,et al. The Human Toxome Project , 2015, ALTEX.
[93] Narsis A Kiani,et al. Systems Toxicology: Systematic Approach to Predict Toxicity. , 2016, Current pharmaceutical design.
[94] Nancy C Baker,et al. Computational Model of Secondary Palate Fusion and Disruption. , 2017, Chemical research in toxicology.
[95] David Dix,et al. A Computational Model Predicting Disruption of Blood Vessel Development , 2013, PLoS Comput. Biol..
[96] T. Hartung. Food for thought ... the first ten years. , 2017, ALTEX.
[97] D. Rall. LABORATORY ANIMAL TESTS AND HUMAN CANCER* , 2000, Drug metabolism reviews.
[98] R. Jilka. The Road to Reproducibility in Animal Research , 2016, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[99] Manuel C. Peitsch,et al. Systems Toxicology: From Basic Research to Risk Assessment , 2014, Chemical research in toxicology.
[100] Corvi Raffaella,et al. EURL ECVAM strategy to avoid and reduce animal use in genotoxicity testing , 2013 .
[101] Mardas Daneshian,et al. Highlight report: Launch of a large integrated European in vitro toxicology project: EU-ToxRisk , 2016, Archives of Toxicology.
[102] Ich Harmonised,et al. INTERNATIONAL COUNCIL FOR HARMONISATION OF TECHNICAL REQUIREMENTS FOR PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED GUIDELINE GENERAL CONSIDERATIONS FOR CLINICAL STUDIES E8(R1) , 2019 .
[103] M. Belvin,et al. RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth , 2010, Nature.
[104] Imran Shah,et al. Toxicology ontology perspectives. , 2012, ALTEX.
[105] J. Kleinjans,et al. Moving Forward in Human Cancer Risk Assessment , 2010, Environmental health perspectives.
[106] Alan D. Lopez,et al. The Global Burden of Disease Study , 2003 .
[107] Aldert H Piersma,et al. Validation of the Rat Limb Bud Micromass Test in the International ECVAM Validation Study on Three In Vitro Embryotoxicity Tests , 2004, Alternatives to laboratory animals : ATLA.
[108] A. Knight,et al. The future of teratology research is in vitro , 2005 .
[109] Gina M. Solomon,et al. Screening for Chemical Contributions to Breast Cancer Risk: A Case Study for Chemical Safety Evaluation , 2015, Environmental health perspectives.
[110] Bertrand Desprez,et al. Non-animal methods to predict skin sensitization (II): an assessment of defined approaches** , 2018, Critical reviews in toxicology.
[111] Thomas Hartung,et al. Toward a New Toxicology — Evolution or Revolution? , 2008, Alternatives to laboratory animals : ATLA.
[112] Thomas Hartung,et al. Opinion versus evidence for the need to move away from animal testing. , 2017, ALTEX.
[113] F. Oesch,et al. Interspecies differences in cancer susceptibility and toxicity. , 1999, Drug metabolism reviews.
[114] Martin Paparella,et al. International regulatory needs for development of an IATA for non-genotoxic carcinogenic chemical substances. , 2016, ALTEX.
[115] Thomas Hartung,et al. Perspectives on In Vitro to In Vivo Extrapolations. , 2017, Applied in vitro toxicology.
[116] J. French,et al. The utility of genetically modified mouse assays for identifying human carcinogens: a basic understanding and path forward. The Alternatives to Carcinogenicity Testing Committee ILSI HESI. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.
[117] Marlene Ågerstrand,et al. Weight of evidence evaluation and systematic review in EU chemical risk assessment: Foundation is laid but guidance is needed. , 2016, Environment international.
[118] Jonathan Balcombe,et al. Animal Carcinogenicity Studies: 2. Obstacles to Extrapolation of Data to Humans , 2006, Alternatives to laboratory animals : ATLA.
[119] R. Tennant,et al. Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S. NTP. , 1991, Mutation research.
[120] David B Duignan,et al. Navigating tissue chips from development to dissemination: A pharmaceutical industry perspective , 2017, Experimental biology and medicine.
[121] Svetlana V. Ukraintseva,et al. Cancer in rodents: does it tell us about cancer in humans? , 2005, Nature Reviews Cancer.
[122] D. Pamies. Good Cell Culture Practice for stem cells and stem-cell-derived models , 2017 .
[123] Mardas Daneshian,et al. Validation and quality control of replacement alternatives - Current status and future challenges , 2012 .
[124] Sebastian Hoffmann,et al. Evidence-based toxicology for the 21st century: opportunities and challenges. , 2013, ALTEX.
[125] J. Wikswo,et al. Fitting tissue chips and microphysiological systems into the grand scheme of medicine, biology, pharmacology, and toxicology , 2017, Experimental biology and medicine.
[126] I. Kola,et al. Can the pharmaceutical industry reduce attrition rates? , 2004, Nature Reviews Drug Discovery.
[127] Bernhard Voelkl,et al. Reproducibility of preclinical animal research improves with heterogeneity of study samples , 2018, PLoS biology.
[128] Alexandra Maertens,et al. Analysis of Public Oral Toxicity Data from REACH Registrations 2008–2014 , 2016, ALTEX.
[129] George Daston,et al. Correlation of chemical structure with reproductive and developmental toxicity as it relates to the use of the threshold of toxicological concern. , 2012, Regulatory toxicology and pharmacology : RTP.
[130] M. Aardema,et al. Use of Syrian hamster embryo and BALB/c 3T3 cell transformation for assessing the carcinogenic potential of chemicals. , 1999, IARC scientific publications.
[131] B. van Ravenzwaay,et al. The threshold of toxicological concern for prenatal developmental toxicity in rabbits and a comparison to TTC values in rats. , 2012, Regulatory toxicology and pharmacology : RTP.
[132] Zuang Valerie,et al. Alternative methods for regulatory toxicology – a state-of-the-art review , 2014 .
[133] Thomas Hartung,et al. Integrated Testing Strategies (ITS) for safety assessment. , 2015, ALTEX.
[134] Zhiyuan Gong,et al. Zebrafish for drug toxicity screening: bridging the in vitro cell-based models and in vivo mammalian models , 2011, Expert opinion on drug metabolism & toxicology.
[135] Raffaella Corvi,et al. ECVAM retrospective validation of in vitro micronucleus test (MNT) , 2008, Mutagenesis.
[136] Gary W Miller,et al. Improving reproducibility in toxicology. , 2014, Toxicological sciences : an official journal of the Society of Toxicology.
[137] T. Hartung. Evidence-based toxicology - the toolbox of validation for the 21st century? , 2010, ALTEX.
[138] W. Thilly. Have environmental mutagens caused oncomutations in people? , 2003, Nature Genetics.
[139] T. Breit,et al. A novel toxicogenomics-based approach to categorize (non-)genotoxic carcinogens , 2014, Archives of Toxicology.
[140] Thomas Hartung,et al. 3D - a new dimension of in vitro research. , 2014, Advanced drug delivery reviews.
[141] Aldert Piersma,et al. The Practical Application of Three Validated In Vitro Embryotoxicity Tests , 2006, Alternatives to laboratory animals : ATLA.
[142] Mardas Daneshian,et al. Recommendation on test readiness criteria for new approach methods in toxicology: Exemplified for developmental neurotoxicity. , 2018, ALTEX.
[143] Michael B Bracken,et al. Is animal research sufficiently evidence based to be a cornerstone of biomedical research? , 2014, BMJ : British Medical Journal.
[144] Sebastian Hoffmann,et al. Food for thought ... on in silico methods in toxicology. , 2009, ALTEX.
[145] Jonathan Balcombe,et al. Animal Carcinogenicity Studies: 1. Poor Human Predictivity , 2006, Alternatives to laboratory animals : ATLA.
[146] Anthony Atala,et al. Organoid-on-a-chip and body-on-a-chip systems for drug screening and disease modeling. , 2016, Drug discovery today.
[147] Corvi Raffaella,et al. Analysis of carcinogenicity testing for regulatory purposes in the European Union , 2016 .
[148] T. Hartung. Food for thought ... on validation. , 2007, ALTEX.
[149] Sangeeta Khare,et al. Non-animal models of epithelial barriers (skin, intestine and lung) in research, industrial applications and regulatory toxicology. , 2015, ALTEX.
[150] Thomas Hartung,et al. Food for thought...on alternative methods for chemical safety testing. , 2010, ALTEX.
[151] David W Gaylor,et al. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens? , 2005, Regulatory toxicology and pharmacology : RTP.
[152] T. Braunbeck,et al. Zebrafish teratogenicity test with metabolic activation (mDarT): effects of phase I activation of acetaminophen on zebrafish Danio rerio embryos. , 2010, Toxicology.
[153] G. Colditz,et al. Preventability of cancer: the relative contributions of biologic and social and physical environmental determinants of cancer mortality. , 2012, Annual review of public health.
[154] Thomas Hartung,et al. Food for thought ... on alternative methods for cosmetics safety testing. , 2008, ALTEX.
[155] J. Huff,et al. Value of Historical Control Data and Other Issues Related to the Evaluation of Long-Term Rodent Carcinogenicity Studies , 1997, Toxicologic pathology.
[156] Melvin E Andersen,et al. Developing microphysiological systems for use as regulatory tools--challenges and opportunities. , 2014, ALTEX.
[157] Mardas Daneshian,et al. Animal use for science in Europe. , 2015, ALTEX.
[158] Daniele Mandrioli,et al. Evidence from Toxicology: The Most Essential Science for Prevention , 2015, Environmental health perspectives.
[159] Robert J Kavlock,et al. In vitro perturbations of targets in cancer hallmark processes predict rodent chemical carcinogenesis. , 2013, Toxicological sciences : an official journal of the Society of Toxicology.
[160] Thomas Hartung,et al. Glossary of reference terms for alternative test methods and their validation. , 2014, ALTEX.
[161] G. Ankley,et al. Application of frog embryo teratogenesis assay‐Xenopus to ecological risk assessment , 2005, Environmental toxicology and chemistry.
[162] V. Rogiers,et al. Inter-laboratory study of human in vitro toxicogenomics-based tests as alternative methods for evaluating chemical carcinogenicity: a bioinformatics perspective , 2015, Archives of Toxicology.
[163] Lutz Müller,et al. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity. , 2005, Mutation research.
[164] F. M. Johnson. Response to Tennant et al.: Attempts to replace the NTP rodent bioassay with transgenic alternatives are unlikely to succeed , 2001 .
[165] Michael Balls,et al. Guidance on Good Cell Culture Practice , 2005, Alternatives to laboratory animals : ATLA.
[166] D. Carlisle. Air of danger. , 1990, Nursing Times.
[167] Gerald T Ankley,et al. Fifteen years after "Wingspread"--environmental endocrine disrupters and human and wildlife health: where we are today and where we need to go. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.
[168] Ali Khademhosseini,et al. Multi-tissue interactions in an integrated three-tissue organ-on-a-chip platform , 2017, Scientific Reports.
[169] T Hartung,et al. The use of embryonic stem cells for regulatory developmental toxicity testing in vitro--the current status of test development. , 2004, Current pharmaceutical design.
[170] Nicole C. Kleinstreuer,et al. Disruption of embryonic vascular development in predictive toxicology. , 2011, Birth defects research. Part C, Embryo today : reviews.
[171] Daniel Morton,et al. An Analysis of Pharmaceutical Experience with Decades of Rat Carcinogenicity Testing , 2011, Toxicologic pathology.
[172] Sebastian Hoffmann,et al. The Emergence of Systematic Review in Toxicology , 2016, Toxicological sciences : an official journal of the Society of Toxicology.
[173] Peter Kasper,et al. Critical analysis of carcinogenicity study outcomes. Relationship with pharmacological properties , 2016, Critical reviews in toxicology.
[174] Martin Paparella,et al. Uncertainty of testing methods--what do we (want to) know? , 2013, ALTEX.
[175] Robert J Kavlock,et al. Developmental toxicity testing for safety assessment: new approaches and technologies. , 2011, Birth defects research. Part B, Developmental and reproductive toxicology.
[176] William Slikker. Of human-on-a-chip and humans: Considerations for creating and using microphysiological systems , 2014, Experimental biology and medicine.
[177] Karl-Heinz Krause,et al. The biological and ethical basis of the use of human embryonic stem cells for in vitro test systems or cell therapy. , 2008, ALTEX.
[178] Thomas Hartung,et al. Systems Toxicology II: A Special Issue. , 2017, Chemical research in toxicology.
[179] B. Aggarwal,et al. Cancer is a Preventable Disease that Requires Major Lifestyle Changes , 2008, Pharmaceutical Research.
[180] Aldert Piersma,et al. A Review of the Implementation of the Embryonic Stem Cell Test (EST) , 2009, Alternatives to laboratory animals : ATLA.
[181] L. Tanoue. Cancer Statistics, 2009 , 2010 .
[182] A. Colacci,et al. Identification of pathway-based toxicity in the BALB/c 3T3 cell model. , 2015, Toxicology in vitro : an international journal published in association with BIBRA.
[183] Thomas B Knudsen,et al. Systems Toxicology , 2015, International journal of toxicology.
[184] J Glanville,et al. Applicability and Feasibility of Systematic Review for Performing Evidence-Based Risk Assessment in Food and Feed Safety , 2015, Critical reviews in food science and nutrition.
[185] B. van Ravenzwaay. Initiatives to decrease redundancy in animal testing of pesticides. , 2010, ALTEX.
[186] David Kirkland,et al. A core in vitro genotoxicity battery comprising the Ames test plus the in vitro micronucleus test is sufficient to detect rodent carcinogens and in vivo genotoxins. , 2011, Mutation research.
[187] J. P. Van Oosterhout,et al. The utility of two rodent species in carcinogenic risk assessment of pharmaceuticals in Europe. , 1997, Regulatory toxicology and pharmacology : RTP.
[188] G J Carr,et al. Validation of alternative methods for toxicity testing. , 1998, Environmental health perspectives.
[189] Alexandra Maertens,et al. Integrated testing strategies for safety assessments. , 2013, ALTEX.
[190] Thomas Hartung,et al. A Modular Approach to the Extended One-generation Reproduction Toxicity Study , 2009, Alternatives to laboratory animals : ATLA.
[191] I. Mangelsdorf,et al. Relevance of non-guideline studies for risk assessment: the coverage model based on most frequent targets in repeated dose toxicity studies. , 2013, Toxicology letters.
[192] Nancy Santesso,et al. GRADE: Assessing the quality of evidence in environmental and occupational health. , 2016, Environment international.
[193] Michael J Joyner,et al. Ten questions about systems biology , 2011, The Journal of physiology.